COMSTECH-NTD NETWORK JOINT LECTURE SERIES “Structure-based drug design: Towards new anti-infectives”
Professor Dr. Ehmke Pohl
Biophysical Sciences Institute at Durham University
Durham, United Kingdom
Date: February 2nd, 2022
Time: 3:00 PM Pak time
NTDs (neglected tropical diseases) are a major health and economic burden in Organisation of Islamic Cooperation (OIC) member states. The control and elimination of NTDs requires both a scale-up and integration of global mass treatment programmes, along with new tools and technologies to tackle these diseases. COMSTECH, in collaboration with A Global Network for Neglected Tropical Diseases (known as the NTD Network, https://ntd-network.org/), is launching a virtual lecture series. for researchers across the Moslem world and beyond. Our programme draws upon expertise from both networks, and offers opportunities to gain or enhance researcher knowledge, skills and connections, all of which help to grow our shared global capacity to tackle these rapidly growing NTDs.
- The NTD Network, funded by UKRI’s Global Challenges Research Fund (GCRF), is a consortium of academic researchers from South America, Asia, and the UK, seeking new therapeutic solutions to leishmaniasis and Chagas disease
- Both COMSTECH and the NTD Network aim to promote global scientific cooperation and build researcher capacity to find new and better therapeutic solutions for NTDs
This online programme is the first of many COMSTECH-NTD Network joint activities via the COMSTECH platform.
This webinar is open to academics, scientists and the general public from all OIC member states. The content is most relevant to scientists interested in NTDs research, and specialised in Microbiology, Genetics, Genomics, Molecular Biology, Molecular Medicine, and Pathology.
Professor Ehmke Pohl graduated in Chemistry (Diplom) at the University of Göttingen, and finished his PhD in 1994 with a thesis on bioactive peptides with Prof. G.M. Sheldrick. He continued his training in protein crystallography as Ernst-Schering Fellow at the University of Washington in Seattle, USA. In 1999 he joined the EMBL Outstation in Hamburg as independent scientist and Team leader. In 2004 he took up a post as principal beam line scientist at the Swiss Light Source responsible for the Max-Planck Society/Novartis/Hoffmann La Roche beam line. In 2007, he moved back to academia to take up a position as Reader in a joint appointment by the Departments of Chemistry and Biosciences at Durham University. In 2015 he become Co-Director of the Biophysical Sciences Institute at Durham University where he pursues his interests in combining biophysical and structural methods with structure-based drug design to combat infectious diseases.
Register with us to attend this meeting:
Register at: https://forms.gle/ppVtofLdn4GzvBca7
Contact us for further details: